[#item_full_content] Q4 FY26 saw double-digit revenue growth, record international sales, and strong gross margins, with continued leadership in key global medical cannabis markets and a robust cash position. Strategic acquisitions and innovation support long-term growth.Original document: Aurora Cannabis Inc. [ACB] Sl… 
Read More
ACB: Q4 FY26 delivered record medical cannabis revenue, strong margins, and global market leadership
ByPot Shop News
June 11, 2026